prof. MUDr. Jiří Mayer, CSc.
Department head, Department of Internal Medicine, Hematology and Oncology
Correspondence Address:
Jihlavská 340/20, 625 00 Brno
Phone: | +420 532 23 3643, 3603 |
---|---|
E‑mail: |
social and academic networks: |
---|
Total number of publications: 1618
2016
-
Léčba 14 případů Castlemanovy nemoci: Zkušenosti jednoho centra a přehled literatury
Vnitřní lékařství, year: 2016, volume: 62, edition: 4
-
Léčba Ph negativních myeloproliferativních neoplázií v roce 2016
Year: 2016, type: Conference abstract
-
Lenalidomide versus investigator's choice in relapsed or refractory mantle cell lymphoma (MCL-002; SPRINT): a phase 2, randomised, multicentre trial
Lancet Oncology, year: 2016, volume: 17, edition: 3, DOI
-
Long-term outcome of patients with newly diagnosed chronic myeloid leukemia - A randomized comparison of stem cell transplantation with drug treatment
Leukemia, year: 2016, volume: 30, edition: 3, DOI
-
Low-Burden TP53 mutations occur in chronic phase of myeloproliferative neoplasms regardless of hydroxyurea administration, disease type and JAK2 status
Year: 2016, type: Conference abstract
-
MicroRNAs in the microenvironmental interactions of B cell leukemias.
Year: 2016, type: Conference abstract
-
Minoritní klony s mutací genu TP53 se vyskytují v chronické fázi myeloproliferativních neoplázií nezávisle na léčbě hydroxyureou
Year: 2016, type: Conference abstract
-
Molekulárně genetické vyšetření u akutní myeloidní leukemie
Klinická onkologie, year: 2016, volume: 29, edition: 6, DOI
-
Mutations in SF3B1 gene are selected independently on ATM/TP53 status and reduce the time to first treatment in CLL patients.
Year: 2016, type: Conference abstract
-
Obinutuzumab plus bendamustine versus bendamustine monotherapy in patients with rituximab-refractory indolent non-Hodgkin lymphoma (GADOLIN): a randomised, controlled, open-label, multicentre, phase 3 trial
Lancet Oncology, year: 2016, volume: 17, edition: 8, DOI